Ad-hoc | 26 June 2001 06:52

MorphoSys AG english

Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– CAT Winter II Lawsuit Dismissed by U.S. Court Martinsried/Munich, Germany, June 26, 2001 — The Munich-based biotechnology company MorphoSys AG (Neuer Markt: MOR) announced today a lawsuit initiated by Cambridge Antibody Technology Ltd. (CAT), together with The Medical Research Council and The Scripps Research Institute, alleging infringement of their “Winter II” US patent (No. 6,248,516) has been dismissed by the United States District Court for the Southern District of California in San Diego. The lawsuit was filed by CAT on June 19, 2001 and was dismissed by the court on Friday, June 22, 2001, for lack of jurisdiction and improper venue. MorphoSys has now filed an action for Declaratory Judgement in the U.S. District Court for the District of Columbia in Washington D.C. In Europe, a related Winter II patent was granted in 1994 and MorphoSys successfully opposed it at the European Patent Office (EPO) in October 1999. In its decision in 1999, the EPO requested substantial changes in the language of the key claim in the patent, thereby significantly narrowing the scope of protection. end of ad hoc announcement (c) DGAP 26.06.2001 ——————————————————————————– WKN: 663200; Index: Nemax 50 Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 260652 Jun 01